Ryan N. Henderson

Array ( [id] => 6887888 [patent_doc_number] => 20010008882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-19 [patent_title] => 'PROCESS OF DELIVERING A POLYNUCLEOTIDE INTO A PARENCHYMAL CELL' [patent_app_type] => new-utility [patent_app_number] => 09/391260 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10389 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20010008882.pdf [firstpage_image] =>[orig_patent_app_number] => 09391260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6886571 [patent_doc_number] => 20010019840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-06 [patent_title] => 'ACTIVE RETINOIC ACID-FREE CULTURE MEDIUM FOR AVIAN TOTIPOTENT EMBRYONIC CELLS' [patent_app_type] => new [patent_app_number] => 09/392506 [patent_app_country] => US [patent_app_date] => 1999-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6027 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20010019840.pdf [firstpage_image] =>[orig_patent_app_number] => 09392506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 720167 [patent_doc_number] => 07049302 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-23 [patent_title] => 'Compositions of CPG and saponin adjuvants and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/369941 [patent_app_country] => US [patent_app_date] => 1999-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5752 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049302.pdf [firstpage_image] =>[orig_patent_app_number] => 09369941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7079012 [patent_doc_number] => 20010041679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'MULTIPLE SITE DELIVERY OF ADENOVIRAL VECTOR FOR THE INDUCTION OF ANGIOGENESIS' [patent_app_type] => new [patent_app_number] => 09/357010 [patent_app_country] => US [patent_app_date] => 1999-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13204 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041679.pdf [firstpage_image] =>[orig_patent_app_number] => 09357010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407572 [patent_doc_number] => 06265212 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Packaging systems for human recombinant adenovirus to be used in gene therapy' [patent_app_type] => 1 [patent_app_number] => 9/356575 [patent_app_country] => US [patent_app_date] => 1999-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 22270 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265212.pdf [firstpage_image] =>[orig_patent_app_number] => 356575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305217 [patent_doc_number] => 06315992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Generating cartilage in a mammal using fibroblasts transfected with a vector encoding TGF-.beta.-1' [patent_app_type] => 1 [patent_app_number] => 9/345415 [patent_app_country] => US [patent_app_date] => 1999-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 9099 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/315/06315992.pdf [firstpage_image] =>[orig_patent_app_number] => 345415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1047006 [patent_doc_number] => 06864402 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-08 [patent_title] => 'Chronic hepatitis virus infection and clonal hepatocellular carcinoma in mouse repopulated livers' [patent_app_type] => utility [patent_app_number] => 09/344189 [patent_app_country] => US [patent_app_date] => 1999-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 19 [patent_no_of_words] => 8200 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864402.pdf [firstpage_image] =>[orig_patent_app_number] => 09344189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814235 [patent_doc_number] => 20020039572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'CHIMERIC MAMMALIAN ALLANTOIS' [patent_app_type] => new [patent_app_number] => 09/336103 [patent_app_country] => US [patent_app_date] => 1999-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24955 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20020039572.pdf [firstpage_image] =>[orig_patent_app_number] => 09336103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474264 [patent_doc_number] => 06387701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Method of identifying tumor antigens that elicit a T-cell response' [patent_app_type] => B1 [patent_app_number] => 09/302329 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11239 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387701.pdf [firstpage_image] =>[orig_patent_app_number] => 09302329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1089767 [patent_doc_number] => 06828472 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-07 [patent_title] => 'Inbred mouse strain selected for autoimmune arthritis' [patent_app_type] => B1 [patent_app_number] => 09/284114 [patent_app_country] => US [patent_app_date] => 1999-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 2508 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828472.pdf [firstpage_image] =>[orig_patent_app_number] => 09284114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533779 [patent_doc_number] => 06410710 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Nucleic acid encoding a TRAF-3 deletion isoform' [patent_app_type] => B1 [patent_app_number] => 09/268544 [patent_app_country] => US [patent_app_date] => 1999-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 29818 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410710.pdf [firstpage_image] =>[orig_patent_app_number] => 09268544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1592737 [patent_doc_number] => 06383481 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Method for transplantation of hemopoietic stem cells' [patent_app_type] => B1 [patent_app_number] => 09/265418 [patent_app_country] => US [patent_app_date] => 1999-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3416 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383481.pdf [firstpage_image] =>[orig_patent_app_number] => 09265418 [rel_patent_id] =>[rel_patent_doc_number] =>)